17,17-dimethyl-18-norandrosta-1,4,13(14)-trien-3-one (77702-25-1)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Benzo[3,4]-18-norandrosta-3,12,15-trien-17- one,6'-ethyl-1',2',3',4',5',6'-hexahydro-7- hydroxy-4,6',8-trimethyl-,(3â,4R,6'R,7â,8R,9â,- 10R,14â)-
- 18-Norandrosta-4,13(17)-dien-3-one,17-methyl- (9CI)
- 16β-hydroxy-17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one
- Cyclopenta[13,17]-18-norandrosta-6,8(14)-diene-3,5,9-triol,3',4',5',17-tetrahydro-4'-(1-hydroxy-2,3-dimethylbutyl)-3'-methyl- (9CI)
- Cyclopenta[13,17]-18-norandrosta-6,8(14)- dien-11-one,3',4',5',17-tetrahydro-3,5,9- trihydroxy-4'-[(1S,2R)-1-hydroxy-2,3- dimethylbutyl]-3'-methyl-,(3â,3'â,4'â,5â,9â,- 17R)-
- 17β-HydroxyMethyl-17α-Methyl-18-norandrosta-1,4,13-trien-3-one
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester
- Gona-1,3,5(10)-trien-17-one,13-ethyl-3-hydroxy-
- 3-Hydroxy-13-propylgona-1,3,5(10)-trien-17-one
- 1/C14H19NO2S/c16-18-15(10-12-6-2-1-3-7-12)11-13-8-4-5-9-14(13)17-18/h1-3,6-7,13-14H,4-5,8-11H2/t13-,14-,18?/m1/s
- Androsta-4,6,8(14)-trien-3-one,17-hydroxy-, (17b)-(9CI)
- 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 3α-Hydroxy-4β-hydroxymethyl-4,8-dimethyl-18-nor-16-oxa-5α-androsta-13(17),14-dien-2-one
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
- Gona-4,9,11-trien-3-one,13-ethyl-17-hydroxy-17-methyl-, (17b)- (9CI)
- 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- (9CI)
- Gona-4,9,11-trien-3-one,17-(acetyloxy)-13- ethyl-7-methyl-,(7R,17â)-